Waki, Yuhei
Kamiya, Satoshi
Li, Yi
Hikage, Makoto
Tanizawa, Yutaka
Bando, Etsuro
Terashima, Masanori
Article History
Accepted: 11 October 2020
First Online: 27 October 2020
Compliance with ethical standards
:
: Masanori Terashima has received personal fees from Taiho, Chugai, Ono, Bristol-Myers Squibb, Yakult, Takeda, Eli Lilly, Pfizer, and Daiichi Sankyo, outside the submitted work. All other authors declare no conflict of interest.
: This study was approved by the institutional review board of Shizuoka Cancer Center (Approval no. J2019-42–2019-1–3).
: Informed consent was waived by the ethical committee owing to the retrospective nature of the study.